4Schiller JH, Harring Ion D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New Eng Med,2002,346: 92-98.
5Anderson H, Hopwood P, Stephens RJ, et al. Gemcitabine plus best suppor tive care(BSC )vs BSC in inoperable non-small cell lung a randomized trial with quality of life the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Iamg Cancer. Br J Cancer, 2000,83 : 447-453.
6Posner M, DreysussA, Norris R. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group. J Nail Cancer Inst, 1999,91:66-72.
7Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol, 2000,18:2095-2103.
8Ranson M, Davidson N, Nicolson M, et al. Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small- cell lung cancer. J Natl Cancer Inst, 2000,92:1074-1080.
6Sun Y,Zhou JC.The dinical tumor hand book of Internal Medicine.3rd.Beijing:People Health Publishing House,1996.30-34.孙燕,周际昌.临床肿瘤内科手册.第3版.北京:人民卫生出版社,1996.30-34.
7Fossella F,Pereira JR,von Pawel J,et al.Randomized,multinational,phase Ⅲ study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer:the TAX 326 study group.J Clin Oncol,2003,21:3016-3024.
8Smith IE,O'Brien ME,Talbot DC,et al.Duration of chemotherapy in advanced non-small-cell lung cancer:a randomized trial of three versus six courses of mitomycin,vinblastine,and cisplatin.J Clin Oncol,2001,19:1336-1343.
9Georgoulias V,Papadakis E,Alexopoulos A,et al.Platinumbased and non-platinum-based chemotherapy in advanced non-small-cell lung cancer:a randomised multicentre trial.Lancet,2001,357:1478-1484.
10Lilenbaum RC,Herndon JE 2nd,List MA,et al.Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer:the cancer and leukemia group B (study 9730).J Clin Oncol,2005,23:190-196.
5Ohe Y,Ohashi Y,Kubota K,et al.Randomized phase Ⅲ study of cisplatin plus irinotecan versus carboplatin plus paclitaxel,cisplatin plus gemcitabine,and cisplatin plus vinorelbine for advanced non-small-cell lung cancel[J].Four-Arm Cooperative Study in Japan Ann Oncol,2007,18(2):317-323.
6Zhang ZL,Liu ZS,Sun Q.Effects of thalidomide on angiogenesis and tumor growth and metastasis of human hepatocellular carcinoma in nude mice[J].World J Gastroenterol,2007,1l(2):216-220.
7Schiller JH,Harrington D,Belani CP,et al.Comparison of four chemotherapy regimens for advanced non-small cell lung cancer[J].N Engl J Med,2002,346(2):92-98.
8Hada MM,Horiuchi T.A case report of chemotherapy with thalidomide,celecoxib and gemcitabine in the treatment of patients with brain metastases[J].J Clin Oncol,2008,33(10):1021-1026.
9Gelati M,Corsini E,Frigerio S,et al.Effects of thalidomide on parameters involved in angiogenesis:an in vitro study[J].J Neurooncol,2003,64(3):193-201.
10Fujita K,Asami Y,Tanaka K,et al.Anti-angiogenic effects of thalidomide:expression of apoptosis-inducible active-caspase-3 in a three-dimensional collagen gel culture of aorta[J].Histochem Cell Biol,2007,122(1):27-33.
